Hippocraticai
Hippocraticai is an Artificial Intelligence (AI) tool for healthcare that pre-trains on trusted, evidence-based content, unlike most langu...
Last verified:
What is Hippocraticai?
Hippocraticai builds the safest generative AI healthcare agent for health systems, payors, and pharma companies. The platform offers over 1,000 AI healthcare agents designed for non-diagnostic, patient-facing clinical and operational tasks such as patient onboarding, adherence engagement, clinical trial coordination, post-market follow-up, chronic care management, post-discharge follow-ups, and pharmaceutical trial coordination. The AI agents do not diagnose or prescribe, ensuring safety in regulated clinical environments.
The platform uses a novel Polaris Constellation architecture with a 5.0T+ parameter constellation where specialized support models increase medical accuracy and safety. Hippocraticai has been clinically validated on outputs, the only company with this distinction. It has been tested with a network of over 7,500 US licensed clinicians on over 725K test calls, with over 180 million clinical interactions recorded. The AI is pre-trained on trusted, evidence-based content rather than common internet crawls, outperforming GPT-4 on 105 out of 114 healthcare exams and certifications.
Hippocraticai is designed for healthcare organizations including health systems, payers, and life-sciences organizations worldwide. The company partners with more than 50 health systems, payers, and life-sciences organizations. The AI agents interact conversationally with patients through voice with ultra-low latency, delivering safe, personalized, and scalable patient engagement solutions. Key use cases include RPM adherence, colorectal screening, drug identification, escalation to human nurses, and motivational interviewing with challenging patients.
The platform delivers measurable outcomes across care settings: 20% higher pre-charting completion rate for MWV intake, 360% increase in team capacity for chronic care management, 30% reduction in readmission rates, 12x average ROI across use cases, 2.6x higher engagement with Spanish-speaking populations for closing care ga
Hippocraticai pricing
Pricing model: Free
Enterprise/healthcare contract basis - pricing is not public. The company charges $9 per agent-hour, with health systems paying only for active agent time spent on patient interactions. This pricing structure aligns costs with actual utilization rather than requiring upfront licensing fees or seat-based subscriptions. No free tier is publicly advertised. Licensing and deployment is by health systems and providers with custom integrations, safety auditing, agent creation, and scaling features included.
Hippocraticai pros
- Clinically validated on outputs - only AI with this distinction
- Over 180 million clinical interactions recorded
- 1,000+ AI healthcare agents available across specialties
- Does not diagnose or prescribe - safety-first approach
- Outperforms GPT-4 on 105 of 114 healthcare exams
- Pre-trained on trusted evidence-based content, not internet crawls
- Polaris Constellation architecture with 5.0T+ parameters
- Tested with 7,500+ US licensed clinicians on 725K test calls
- Ultra-low latency voice interactions with patients
- Partners with 50+ health systems and payers worldwide
- 12x average ROI across different use cases
- 30% reduction in readmission rates demonstrated
- 360% increase in team capacity for chronic care
- Specialized support models increase medical accuracy
- 22 models with multi-step certification process
- Patent awarded for safety architecture
- Motivational interviewing and empathy built into agents
- Automatic escalation to human nurses when needed
- Health equity focus with 2.6x higher Spanish engagement
- $404 million raised from leading investors including Andreessen Horowitz
Hippocraticai cons
- No public pricing - enterprise contract basis only
- No free tier publicly advertised
- Does not diagnose or prescribe - limited clinical scope
- Marketplace limited to verified US licensed clinicians only
- Not an open consumer app store - restricted creation
- Requires custom integrations with health systems
- Safety auditing and certification process is rigorous
- Primarily focused on US healthcare system
- /clients must be healthcare organizations, not individuals
- Agent creators receive only 5% of base customer rate
Frequently asked questions about Hippocraticai
Does Hippocratic AI's AI diagnose or prescribe medications?
No, Hippocratic AI's AI agents do not diagnose or prescribe. The platform focuses on non-diagnostic, patient-facing clinical and operational tasks. This is a core safety principle - the company established that their products must be as safe as an average human performing the same task, with safety prioritized above all else.
What is the Polaris Constellation architecture?
The Polaris Constellation architecture is a novel 5.0T+ parameter architecture where 22 specialized support models work together to increase medical accuracy and safety. It uses multi-step certification with thousands of clinicians and hundreds of thousands of test calls, allowing new agents to plug into an already validated runtime instead of starting from zero.
How has Hippocratic AI been clinically validated?
Hippocratic AI is the only company clinically validated on outputs. It was tested with a network of over 7,500 US licensed clinicians on over 725K test calls. The AI has recorded over 180 million clinical interactions across 1,000+ use cases and has outperformed GPT-4 on 105 out of 114 healthcare exams and certifications.
What types of healthcare agents are available?
Hippocratic AI offers over 1,000 AI healthcare agents across 25+ specialties including Allergy, Cardiology, Dental, Diabetes, ENT, Gastroenterology, General, Geriatric, Medicare Advantage, Nephrology, Neurology, OB/GYN, Oncology, Ophthalmology, Orthopedics, Pharma, Primary Care, and Urology. Agents cover goals like quality improvement, care management, readmission prevention, health equity, compliance, and chronic care coaching.
Who can create agents in the Hippocratic AI marketplace?
The marketplace is not open - creation is limited to verified US licensed clinicians only. Hippocratic provides a no-code Agent Trainer, reviews all submissions, and pays creators 5% of the base customer rate (typically $10 per hour). This structure attracts domain experts while keeping clinical quality and economics under Hippocratic's control.
What is the pricing model for health systems?
Hippocratic AI charges $9 per agent-hour, with health systems paying only for active agent time spent on patient interactions. This aligns costs with actual utilization rather than requiring upfront licensing fees or seat-based subscriptions. Pricing is on an enterprise/healthcare contract basis and is not publicly advertised.
What outcomes does Hippocratic AI deliver?
Key outcomes include: 20% higher pre-charting completion rate, 360% increase in team capacity for chronic care management, 30% reduction in readmission rates, 12x average ROI across use cases, 2.6x higher engagement with Spanish-speaking populations, 60% of completed calls resulting in documented vaccination goals, and 89% connection rate for public service announcements.
What investors have backed Hippocratic AI?
Hippocratic AI has raised $404 million total from leading investors including Andreessen Horowitz, General Catalyst, Kleiner Perkins, Avenir, NVIDIA's NVentures, Premji Invest, SV Angel, Google's CapitalG, and numerous health systems. The company was founded in February 2023.
How does Hippocratic AI ensure safety?
Safety is the top priority - everyone takes an oath before the company pledging to prioritize product safety above all else. The company has a 'Do No Harm' value requiring products to be as safe as an average human performing the same task. Hippocratic received a patent for their safety architecture and uses rigorous internal testing with 7,500+ licensed clinicians.
What partnerships does Hippocratic AI have?
Hippocratic AI partners with more than 50 health systems, payers, and life-sciences organizations worldwide. Key partners include Cincinnati Children's Global and organizations representing networks of over 7,500 US licensed clinicians. The company also has a strategic collaboration with BCG to deploy agentic AI across biopharma and medtech industries.